Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 3, 2004 - Issue 2
Submit an article Journal homepage
644
Views
67
CrossRef citations to date
0
Altmetric
Review

Safety and side effects of the acne drug, oral isotretinoin

A Charakida Department of Dermatology, Hammersmith Hospital Campus, Imperial College, Du Cane Road, London W12 0NN, UK. [email protected]
,
PE Mouser Department of Dermatology, Hammersmith Hospital Campus, Imperial College, Du Cane Road, London W12 0NN, UK. [email protected]
&
AC Chu Department of Dermatology, Hammersmith Hospital Campus, Imperial College, Du Cane Road, London W12 0NN, UK. [email protected]
Pages 119-129 | Published online: 03 Mar 2005

Bibliography

  • MARCELO CL, MADISON KC: Regulation of the expression of epidermal keratinocyte proliferation and differentiation by vitamin A analogs. Arch. Dermatol Res. (1984) 276(6):381–389.
  • TORIVIA H: Interaction of isotretinoin with endogenous retinoids. Am. Acad. Dermatol (2001) 45(5):5143–5149.
  • STRAUSS JS, STRANIERI AM, FARRELL LN, DOWNING DT: effect of marked inhibition of sebum production with 13cis-retinoic acid on skin surface lipid composition. .1. Invest. Dermatol (1980) 74(2):66–67.
  • KING K, JONES DH, DALTREY DC, CUNLIFFE WJ: A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br. .1. Dermatol (1982) 107(5):583–590.
  • PIGATTO PD, FIORONI A, RIVA F et al: Effects of isotretinoin on the neutrophil chemotaxis in cystic acne. (1983) 167(1):16–18.
  • FALCON RH, LEE WL, SHALITA AR, SUNTHARALINGAM K, FIKRIG SM: In vitro effect of isotretinoin on monocyte chemotaxis. Invest. Dermatol (1986) 86(5):550–552.
  • JONES DH: A comparison of 13-cis-retinoic acid and erythromycin treatment in severe acne. Br. J. Dermatol (1983) 109\(Suppl. 24):27–28.
  • LANGNER A, WOLSKA H, M, JABLONSKA S, MAJEWSKI S: 13-cis-Retinoic acid and tetracycline versus 13-cis-retinoic acid alone in the treatment of nodulocystic acne. Dermatologica (1985) 170(4):185–188.
  • WESSELS F, ANDERSON AN, KROPMAN K: The cost-effectiveness of isotretinoin in the treatment of acne. Part 1. A meta-analysis of effectiveness literature. S. Afr. Med. J. (1999) 89(7 Pt 2):780–784.
  • CHIVOT M, MIDOUN H: and acne - a study of relapses. (1990) 180(4):240–243.
  • LAYTON AM: Ten year's experience of oral isotretinoin for the treatment of acne vulgaris. Dermatolog. Treat. (1993) 4\(Suppl. 2):52–55.
  • LEHUCHER-CEYRAC D,-BUISSET MJ: Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years. Dermatology (1993) 186(2):123–128.
  • LEHUCHER-CEYRAC D, DE LA SP, CHASTANG C, MOREL P: factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients. Dermatology (1999) 198(3):278–283.
  • WHITE GM, CHEN W, YAO J,-TSADIK G: Recurrence rates after the first course of isotretinoin. Dermatol (1998) 134(3):376–378.
  • HANSON N, LEACHMAN S: Safety issues in isotretinoin therapy. &min. Caton. Med. Surg. (2001) 20(3):166–183.
  • ••A thorough review of the side effects oforal isotretinoin.
  • UHL K, KENNEDY DL, KWEDER SL: Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs. Drug Sal (2002) 25(12):885–892.
  • ELLIS CN, KRACH KJ: and complications of isotretinoin therapy. Am. Acad. Dermatol (2001) 45(5):S150–S157.
  • CHAN A, HANNA M, ABBOTT M, KEANE RJ: Oral retinoids and pregnancy. Med. J. Aust. (1996) 165(3):164–167.
  • NO AUTHORS LISTED:-exposed pregnancies - California, 1999. MMWR Moth. Mortal. Wkly Rep. (2000) 49(2):28–31.
  • PERLMAN SE, LEACH EE, L, RUSZKOWSKI AM, RUDY SJ: 'Be smart, be safe, be sure'. The revised Pregnancy Prevention Program for women on isotretinoin. Reprod. Med. (2001) 46(2 Supp1):179–185.
  • LOWENSTEIN EJ: Isotretinoin made SMART. and simple. Culls (2002) 70(2):115–120.
  • •A detailed review of the side effects of oral isotretinoin.
  • HULL PR, DEMKIW-BARTEL C: Isotretinoin use in acne: prospective evaluation of adverse events. j. Caton. Med. Surg. (2000) 4(2):66–70.
  • MCLANE J: Analysis of common side effects of isotretinoin. Am. Acad. Dermatol (2001) 45(5):5188–5194.
  • •A thorough analysis of common side effects of oral isotretinoin.
  • BETTOLI V, TOSTI A, VAROTTI C: Nummular eczema during isotretinoin treatment. Am. Acad. Dermatol (1987) 16(3 Pt 1):617.
  • TAIEB A, MALEVILLE J: dermatitis mimicking 'eczema craquele'. Acta Derm. Venereol (1985) 65(6):570.
  • HELFMAN RJ, BRICKMAN M, FAHEY J: Isotretinoin dermatitis simulating acute pityriasis rosea. Cutts (1984) 33(3):297–300.
  • LEYDEN JJ: The role of isotretinoin in the treatment of acne: personal observations. J. Am. Acad. Dermatol (1998) a39(2 Pt 3):S45–S49.
  • KAPUR N, HUGHES JR, RUSTIN MH: Exacerbation of asthma by isotretinoin. Br. J. Dermatol (2000) 142(2):388–389.
  • SABROE RA, STAUGHTON RC, BUNKER CB: Bronchospasm induced by isotretinoin. Br. Med. .1 (1996) 312(7035):886.
  • HOLMES SC, THOMSON J: Isotretinoin and skin fragility. Br. J. Dermatol (1995) 132(1):165.
  • ZACHARIAE H: Delayed wound healing and keloid formation following argon laser treatment or dermabrasion during isotretinoin treatment. Br. J. Dermatol (1988) 118(5):703–706.
  • GOLFARB MT: The uses of retinoids in dermatology. Carr. Opin. Dermatol (1997) 4:236–240.
  • WOOLLONS A, PRICE ML: Roaccutane and wax epilation: a cautionary tale. Br. J. Dermatol (1997) 137(5):839–840.
  • CAMPBELL JP, GREKIN RC, ELLIS CN, MATSUDA-JOHN SS, SWANSON NA, VOORHEES JJ: Retinoid therapy is associated with excess granulation tissue responses. J. Am. Acad. Dermatol (1983) 9(5):708–713.
  • CUNLIFFE WJ: Side-effects of acne therapy. In: Acne. M Dunitz (Ed.), London, UK (1989):311.
  • CHOI EH, BANG D: Acne fulminans and 13-cis-retinoic acid. Dermatol (1992) 19(6):378–383.
  • ELIAS LM, GOMEZ MI, TORRELO A, BOIXEDA JP, LEDO A: Acne fulminans and bilateral seronegative sacroiliitis triggered by isotretinoin. Dermatol (1991) 18(6):366–367.
  • SEUKERAN DC, CUNLIFFE WJ: The treatment of acne fulminans: a review of 25 cases. Br. J. Dermatol (1999) 141(2):307–309.
  • TAN BB, LEAR JT, SMITH AG: Acne fulminans and erythema nodosum during isotretinoin therapy responding to dapsone. Clin. Exp. Dermatol. (1997) 22(1):26–27.
  • LEYDEN JJ: Oral isotretinoin. How can we treat difficult acne patients? Dermatology (1997) 195\(Suppl. 1):29–33.
  • CHIVOT M: [Acne flare-up and deterioration with oral isotretinoin]. Ann. Dermatol Venereol. (2001) 128(3 Pt 1):224–228. French.
  • ONDER M, OZTAS MO, OZTAS P: Isotretinoin-induced nail fragility and onycholysis. Dermot°log. Treat. (2001) 12(2):115–116.
  • STETSON CL, BUTLER DF, RAPINI RP: Herpetic whitlow during isotretinoin therapy. Int. J Dermatol (2003) 42(6):496–498.
  • DHARMAGUNAWARDENA B, CHARLES-HOLMES R: canaliform dystrophy following isotretinoin therapy. Br. J. Dermatol (1997) 137(4):658–659.
  • DE RAEVE L, WILLEMSEN M, DE CONINCK A, ROSEEUW D: [Paronychia and the formation of granulation tissue during isotretinoin therapy]. Dermatologica (1986) 172(5):278–280. French.
  • STRAUSS JS, GOTTLIEB AB, JONES T et al.: Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: a randomized trial. Am. Acad. Dermatol (2000) 43(5 Pt 1):777–784.
  • FIALLO P, TAGLIAPIETRA AG: Severe acute myopathy induced by isotretinoin. Arch. Dermatol (1996) 132(12):1521–1522.
  • LOMBARDO JA, BERGFELD WF, BERGFELD JA: Strenuous exercise and elevated creatine phosphokinase in patients taking isotretinoin.j Am. Acad. Dermatol (1985) 12(3):580.
  • GERBER LH, HELFGOTT RK, GROSS EG, HICKS JE, ELLENBERG SS, PECK GL: Vertebral abnormalities associated with synthetic retinoid use. J. Am. Acad. Dermatol (1984) 10(5 Pt 1):817–823.
  • KILCOYNE RE COPE R, CUNNINGHAM W et al.: spinal hyperostosis with low-dose isotretinoin therapy. Invest. Radial. (1986) 21(1):41–44.
  • DIGIOVANNA JJ: Isotretinoin effects on bone. J. Am. Acad. Dermatol (2001) 45 (5):S176–5182.
  • ••A detailed review of the skeletal effectsof isotretinoin.
  • ATALAY A, ALTAYKAN A, ERGIN G, KUTSAL YG: Reversible sclerotic changes of lumbar spine and femur due to long-term oral isotretinoin therapy. Rheumatol Int. (2003). Epublished ahead of print.
  • KELLER KL, FENSKE NA: of vitamins A, C, and E and related in dermatology: a review. Am. Acad. Dermatol (1998) 39(4 Pt 1):611–625.
  • MILSTONE LM, MCGUIRE J, RC: Premature epiphyseal closure in a child receiving oral 13-cis-retinoic acid. J. Am. Acad. Dermatol. (1982) 7(5):663–666.
  • MARINI JC, HILL S, ZASLOFF MA: Dense metaphyseal bands and growth arrest associated with isotretinoin therapy. J. Dis. Child. (1988) 142(3):316–318.
  • STANDEVEN AM, DAVIES PJ, CHANDRARATNA RA, MADER DR, JOHNSON AT, THOMAZY VA: Retinoid-induced epiphyseal plate closure in guinea pigs. Fundam. Appl. Toxicol (1996) 34(1):91–98.
  • FRAUNFELDER FT, FW, EDWARDS R: Ocular side effects possibly associated with isotretinoin usage. kn. I Ophthalmol (2001) 132(3):299–305.
  • ••A thorough review of the ocular side effectsof isotretinoin.
  • BOZKURT B, IRKEC MT, ATAKAN N, ORHAN M, GEYIK PO: function and ocular complications in patients treated with systemic isotretinoin. Eur: Ophthalmol. (2002) 12(3):173–176.
  • ELLIES P, DIGHIERO P, LEGEAIS JM,POULIQUEN YJ, RENARD G: corneal opacity after oral isotretinoin therapy for acne. Cornea (2000) 19(2):238–239.
  • WELEBER RG, DENMAN ST, HANIFIN JM, CUNNINGHAM WJ: Abnormal retinal function associated with isotretinoin therapy for acne. Ophthalmol. (1986) 104(6):831–837.
  • AZURDIA RIVI, SHARPE GR: treatment for acne vulgaris and its cutaneous and ocular side-effects. Br: J. Dermatol (1999) 141(5):947.
  • HULL PR, D'ARCY C: Isotretinoin use and subsequent depression and suicide: presenting the evidence. Am. I Gin. Dermatol (2003) 4(7):493–505.
  • ••A detailed analysis of evidence associating and psychiatric disorders.
  • NG CH, TAM MM, CELI E, TATE B, SCHWEITZER I: Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Australas. Dermatol (2002) 43(4):262–268.
  • NG CH, SCHWEITZER I: The association between depression and isotretinoin use in acne. Aust. NZ J. Psychiatry(2003) 37(1):78–84.
  • ••A critical review of literature on depressionand isotretinoin.
  • WYSOWSKI DK, PITTS M, BEITZ J: Depression and suicide in patients treated with isotretinoin. N Engl. I Med. (2001) 344(6):460.
  • JICK SS, KREMERS HM, VASILAKIS-SCARAMOZZA C: Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch. Dermatol (2000) 136(10):1231–1236.
  • LAYTON AM, SEUKERAN D, CUNLIFFE WJ: Scarred for life? Dermatology (1997) 195 (Suppl. 1):15–21.
  • KELLETT SC, GAWKRODGER DJ: The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br. I Dermatol (1999) 140(2):273–282.
  • HULL SM, CUNLIFFE WJ, BR: Treatment of the depressed and dysmorphophobic acne patient. Exp. Dermatol. (1991) 16(3):210–211.
  • RUBINOW DR, PECK GL, KM, GANTT GG: anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. Am. Acad. Dermatol (1987) 17(1):25–32.
  • O'DONNELL J: Overview of existing research and information linking isotretinoin (accutane), depression, psychosis, and suicide. Am. J. Ther: (2003) 10(2):148–159.
  • GOODMAN AB: Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc. Nati Acad. Sci. USA (1998) 95(13):7240–7244.
  • ••A very interesting analysis of possible relating isotretinoin and psychiatric disorders.
  • ADAMS J, LAMMER EJ: Neurobehavioral teratology of isotretinoin. Reprod. Toxicol (1993) 7(2):175–177.
  • ASKMARK H, LUNDBERG PO, OLSSON S: Drug-related headache. Headache (1989)29(7):441–444.
  • NIKIFORIDIS G, TSAMBAOS D, KARAMITSOS D, KOUTSOJANNIS C, GEORGIOU S: Effects of oral isotretinoin on human auditory brainstem response. Dermatology (1994) 189(1):62–64.
  • LEE AG: Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Culls (1995) 55(3):165–168.
  • ROYTMAN M, FRUMKIN A, TG: Pseudotumor cerebri caused by isotretinoin. Cutts (1988) 42(5):399–400.
  • SPECTOR RH, CARLISLE J: cerebri caused by a synthetic vitamin A preparation. Neurology (1984) 34(11):1509–1511.
  • GERBER A, RAAB AP, SOBEL AE: Vitamin A poisoning in adults; with description of a case. J. Med. (1954) 16(5):729–745.
  • RENTERS DE, HOWARD JM: Isotretinoin-induced inflammatory bowel disease in an adolescent. Ann. Pharmacother. (2001) 35(10):1214–1216.
  • BRUNO NP, BEACHAM BE, BURNETT JW: Adverse effects of isotretinoin therapy. Cutts (1984) 33(5):484–486,489.
  • SCHLEICHER SM: Oral isotretinoin and inflammatory bowel disease. J. Am. Acad. Dermatol (1985) 13(5 Pt 1):834–835.
  • GODFREY KM, JAMES MP: of severe acne with isotretinoin in patients with inflammatory bowel disease. Br: J. Dermatol (1990) 123(5):653–655.
  • AZON-MASOLIVER A, GRAU C: Acute appendicitis and isotretinoin. A coincidence?" Ear: Acad. Dermatol Venereol (2000) 14(3):233–234.
  • AMICHAI B, GRUNWALD MH, ODES SH, ZIRKIN H: Acute esophagitis caused by isotretinoin. hat. J. Dermatol (1996) 35(7):528–529.
  • MARTIN P, MANLEY PN, DEPEW WT, BLAKEMAN JM: Isotretinoin-associated proctosigmoiditis. Gastroenterology (1987) 93(3):606–609.
  • KAPLAN G, HAETTICH B: symptoms due to retinoids. Baillieres Clin. Rheumatol (1991) 5(1):77–97.
  • CAMISA C: Acute arthritis during isotretinoin therapy for acne. J. Am. Acad. Dermatol (1986) 15(5 Pt 1):1061–1062.
  • MATSUOKA LY, WORTSMAN J, PEPPER JJ: Acute arthritis during isotretinoin treatment for acne. Arch. Intern. Med. (1984) 144(9):1870–1871.
  • LEIBOVITCH I, AMITAL H, LEVY Y, LANGEVITZ P, SHOENFELD Y: Isotretinoin-induced adult onset disease. Clin. Exp. Rheumatol (2000) 18(5):616–618.
  • HUGHES RA: Arthritis precipitated by isotretinoin treatment for acne vulgaris. Rheumatol (1993) 20(7):1241–1242.
  • LEHUCHER-CEYRAC D,-BUISSET MJ: Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years. Dermatology (1993) 186(2):123–128.
  • ARACTINGI S, LASSOUED K, DUBERTRET L: Post-isotretinoin vasculitis. Lancet (1990) 335(8685):362.
  • REYNOLDS P, FAWCETT H, WALDRAM R, PROUSE P: Delayed onset of vasculitis following isotretinoin. Lancet (1989) 2(8673):1216.
  • DWYER JM, KENICER K, BT et al.: Vasculitis and retinoids. Lancet (1989) 2 (8661):494–496.
  • EPSTEIN EH Jr, MCNUTT NS, BEALLO R et al.: Severe vasculitis during isotretinoin therapy. Arch. Dermatol (1987) 123(9):1123–1125.
  • FISHER DA: Exercise-induced related to isotretinoin therapy. Am. Acad. Dermatol (1985) 13(3):524.
  • EDWARDS S, SONNEX C: associated with isotretinoin therapy. Acta Derm. Venereol (1997) 77(4)330.
  • PAVESE P, KUENTZ F, BELLEVILLE C, ROUGE PE, ELSENER M: impairment induced by isotretinoin. Nephrol Dial. Transplant. (1997) 12(6):1299.
  • VAN OERS JA, DE LEEUW J, VAN BOMMEL EF: Nephrotic syndrome associated with isotretinoin. Nephrol Dial. Transplant. (2000) 15(6):923–924.
  • CHRISTMAS T: Roaccutane and menorrhagia. Am. Acad. Dermatol (1988) 18(3):576–577.
  • LOUGHNEY AD, REDFERN CP: Menstrual cycle related differences in the proliferative responses of cultured human endometrial stromal cells to retinoic acid. Feral (1995) 105(1):153–159.
  • COLEMAN R, MACDONALD D: Effects of isotretinoin on male reproductive system. Lancet (1994) 344(8916):198.
  • BOUDOU P, SOLIMAN H, CHIVOT M et al.: Effect of oral isotretinoin treatment on skin androgen receptor levels in male acneic patients." Clin. Endocrinol Metab. (1995) 80(4):1158–1161.
  • SADEK IA, ABDUL-MOHSEN MH: Long-term administration of vitamin A and the process of spermatogenesis. Mediterr. Health' (1999) 5(1):123–129.
  • GUNSTON G, MEHTA U, VAN DE WB: New warnings on the use of isotretinoin (Roaccutane). S. Afr. Med. J. (1998) 88(11):1394.
  • STAELS B: Regulation of lipid and lipoprotein metabolism by retinoids. I Am. Acad. Dermal& (2001) 45(5):5158–5167.
  • •A thorough analysis of one of the side effects of isotretinoin.
  • ALCALAY J, LANDAU M, ZUCKER A: Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests?. Treat. (2001) 12(1):9–12.
  • MCCARTER TL, CHEN YK: hyperlipidemia and pancreatitis associated with isotretinoin therapy. Am. J. Gastroenterol (1992) 87(12):1855–1858.
  • FLYNN WJ, FREEMAN PG, LG: Pancreatitis associated with isotretinoin-induced hypertriglyceridemia. Intern. Med. (1987) 107(1):63.
  • ALTMAN RS, ALTMAN LJ, ALTMAN JS: A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris. Dermatology (2002) 204(3):232–235.
  • MANTEL-TEEUWISSE AK, KLOOSTERMAN JM,-VAN DER ZEE AH, KLUNGEL OH, PORSIUS AJ, BOER A: Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Sal (2001) 24(6):443–456.
  • MICHAELSSON G, VAHLQUIST A, MOBACKEN H et al: in laboratory variables induced by isotretinoin treatment of acne. Dem. Venereal (1986) 66(2):144–148.
  • SCHULPIS KH, KARIKAS GA, GEORGALA S, MICHAS T, TSAKIRIS S: Elevated plasma homocysteine levels in patients on isotretinoin therapy for cystic acne. bt.j Del-plata (2001) 40(1):33–36.
  • KOISTINEN HA, REMITZ A, GYLLING H, MIETTINEN TA, KOIVISTO VA, EBELING P: and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid. Diabetes Metab. Res. Rev (2001) 17(5):391–395.

Website

  • http://www.fda.gov/cder/foi/labe1/2002/ 18662s0511131.pdf FDA, Center for Drug Evaluation and Research. Accutane label (revised) 2002 drug information.
  • ••The more recent guidelines on the use ofisotretinoin therapy in the US.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.